PAVmed Q3 Adj. EPS $(0.19) Beats $(0.59) Estimate, Sales $41.000K Beat $25.000K Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.59) by 67.8 percent. This is a 68.33 percent increase over losses of $(0.60) per share from the same
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.59) by 67.8 percent. This is a 68.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $41.000 thousand which beat the analyst consensus estimate of $25.000 thousand by 64.00 percent. This is a 720.00 percent increase over sales of $5.000 thousand the same period last year.